Porto-Álvarez, J.; Martínez, A.M.; Martínez Fernández, J.; Sanmartín López, M.; Blanco Ulla, M.; Vázquez Herrero, F.; Pumar, J.M.; Rodríguez-Yáñez, M.; Minguillón Pereiro, A.M.; Bolón Villaverde, A.; Iglesias Rey, R.; Souto-Bayarri, M. How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke? Appl. Sci.2023, 13, 10061.
Porto-Álvarez, J.; Martínez, A.M.; Martínez Fernández, J.; Sanmartín López, M.; Blanco Ulla, M.; Vázquez Herrero, F.; Pumar, J.M.; Rodríguez-Yáñez, M.; Minguillón Pereiro, A.M.; Bolón Villaverde, A.; Iglesias Rey, R.; Souto-Bayarri, M. How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke? Appl. Sci. 2023, 13, 10061.
Porto-Álvarez, J.; Martínez, A.M.; Martínez Fernández, J.; Sanmartín López, M.; Blanco Ulla, M.; Vázquez Herrero, F.; Pumar, J.M.; Rodríguez-Yáñez, M.; Minguillón Pereiro, A.M.; Bolón Villaverde, A.; Iglesias Rey, R.; Souto-Bayarri, M. How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke? Appl. Sci.2023, 13, 10061.
Porto-Álvarez, J.; Martínez, A.M.; Martínez Fernández, J.; Sanmartín López, M.; Blanco Ulla, M.; Vázquez Herrero, F.; Pumar, J.M.; Rodríguez-Yáñez, M.; Minguillón Pereiro, A.M.; Bolón Villaverde, A.; Iglesias Rey, R.; Souto-Bayarri, M. How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke? Appl. Sci. 2023, 13, 10061.
Abstract
Acute ischemic stroke (AIS) is the loss of neurological function due to a sudden reduction in cerebral blood flow and is a leading cause of disability and death worldwide. In recent years, the field of radiological imaging has experienced an explosion that may reach unprecedented heights with the advent of artificial intelligence. One of the latest innovations in artificial intelligence is radiomics, which is based on the fact that a large amount of quantitative data can be extracted from radiological images, from which patterns can be identified and associated with specific pathologies. Since its inception, radiomics has been particularly associated with the field of oncology, with promising results in a wide range of clinical situations. The performance of radiomics in non-tumour pathologies has been increasingly explored in recent years and the results continue to be promising. The aim of this review is to explore the potential applications of radiomics in AIS patients and to theorise how radiomics may change the paradigm for these patients in the coming years.
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.